Literature DB >> 18333157

Prevention of hepatocellular carcinoma.

Michael C Kew1.   

Abstract

Entities:  

Year:  2005        PMID： 18333157      PMCID： PMC2023918          DOI： 10.1080/13651820410024030

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN： 1365-182X            Impact factor:   3.647


× No keyword cloud information.
  51 in total

1.  Long-term interferon therapy for 1 year or longer reduces the hepatocellular carcinogenesis rate in patients with liver cirrhosis caused by hepatitis C virus: a pilot study.

Authors:  K Ikeda; S Saitoh; M Kobayashi; Y Suzuki; F Suzuki; A Tsubota; Y Arase; N Murashima; K Chayama; H Kumada
Journal:  J Gastroenterol Hepatol       Date:  2001-04       Impact factor: 4.029

Review 2.  Translational strategies for cancer prevention in liver.

Authors:  Thomas W Kensler; Geng-Sun Qian; Jian-Guo Chen; John D Groopman
Journal:  Nat Rev Cancer       Date:  2003-05       Impact factor: 60.716

3.  [Laboratory study on the relationship between drinking water and hepatoma--quantitative evaluation using hepatic gamma-GT method].

Authors:  T L Zhou; S Z Yu
Journal:  Zhonghua Yu Fang Yi Xue Za Zhi       Date:  1990-07

4.  Suppression of HBsAg production in PLC/PRF/5 human hepatoma cell line by interferons.

Authors:  Y Yamashita; K Koike; M Takaoki; S Matsuda
Journal:  Microbiol Immunol       Date:  1988       Impact factor: 1.955

5.  Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan.

Authors:  R P Beasley; L Y Hwang; C C Lin; C S Chien
Journal:  Lancet       Date:  1981-11-21       Impact factor: 79.321

6.  Chlorophyllin intervention reduces aflatoxin-DNA adducts in individuals at high risk for liver cancer.

Authors:  P A Egner; J B Wang; Y R Zhu; B C Zhang; Y Wu; Q N Zhang; G S Qian; S Y Kuang; S J Gange; L P Jacobson; K J Helzlsouer; G S Bailey; J D Groopman; T W Kensler
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-27       Impact factor: 11.205

7.  Long-term treatment of chronic hepatitis C with glycyrrhizin [stronger neo-minophagen C (SNMC)] for preventing liver cirrhosis and hepatocellular carcinoma.

Authors:  Hiromitsu Kumada
Journal:  Oncology       Date:  2002       Impact factor: 2.935

8.  Dietary iron overload as a risk factor for hepatocellular carcinoma in Black Africans.

Authors:  E Mandishona; A P MacPhail; V R Gordeuk; M A Kedda; A C Paterson; T A Rouault; M C Kew
Journal:  Hepatology       Date:  1998-06       Impact factor: 17.425

9.  Inhibition of CYP1A2 and CYP3A4 by oltipraz results in reduction of aflatoxin B1 metabolism in human hepatocytes in primary culture.

Authors:  S Langouët; B Coles; F Morel; L Becquemont; P Beaune; F P Guengerich; B Ketterer; A Guillouzo
Journal:  Cancer Res       Date:  1995-12-01       Impact factor: 12.701

Review 10.  Resolution of liver cirrhosis and prevention of hepatocellular carcinoma by interferon therapy against chronic hepatitis C.

Authors:  M Omata; H Yoshida
Journal:  Scand J Gastroenterol Suppl       Date:  2003
View more
  1 in total

Review 1.  Preclinical Pharmacokinetics, Pharmacodynamics and Safety of Sucroferric Oxyhydroxide.

Authors:  Mario Cozzolino; Felix Funk; Viatcheslav Rakov; Olivier Phan; Isaac Teitelbaum
Journal:  Curr Drug Metab       Date:  2014       Impact factor: 3.731
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.